|
MAP7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.410100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.451900E-02 |
| Normal-vs-Stage2 |
1.992010E-01 |
| Normal-vs-Stage3 |
1.956800E-01 |
| Normal-vs-Stage4 |
1.587800E-01 |
| Stage1-vs-Stage2 |
8.665400E-01 |
| Stage1-vs-Stage3 |
9.737600E-01 |
| Stage1-vs-Stage4 |
7.987000E-01 |
| Stage2-vs-Stage3 |
8.524200E-01 |
| Stage2-vs-Stage4 |
9.017200E-01 |
| Stage3-vs-Stage4 |
7.718000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.444650E-01 |
| Normal-vs-AfricanAmerican |
1.661690E-02 |
| Normal-vs-Asian |
4.091600E-02 |
| Caucasian-vs-AfricanAmerican |
1.363230E-01 |
| Caucasian-vs-Asian |
3.264400E-01 |
| AfricanAmerican-vs-Asian |
4.358600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.215550E-02 |
| Normal-vs-Female |
9.272600E-01 |
| Male-vs-Female |
4.279800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.196300E-02 |
| Normal-vs-Extreme_Weight |
3.544000E-03 |
| Normal-vs-Obese |
1.570370E-01 |
| Normal-vs-Extreme_Obese |
6.630600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.102800E-01 |
| Normal_Weight-vs-Obese |
7.168600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.501760E-01 |
| Extreme_Weight-vs-Obese |
1.440990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.475640E-01 |
| Obese-vs-Extreme_Obese |
2.252000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.374570E-01 |
| Normal-vs-Age(41-60Yrs) |
1.962790E-01 |
| Normal-vs-Age(61-80Yrs) |
3.741800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.949200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.749200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.956200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.877600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.020000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.493600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.887400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.672500E-02 |
| Normal-VS-Type2 PRCC |
7.612200E-01 |
| Normal-VS-KIRP CIMP |
1.942210E-02 |
| Normal-VS-Unclassified PRCC |
7.768000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.050200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.897800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.259000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.074200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.104800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.455600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.383590E-02 |
| Normal-vs-N1 |
7.018800E-01 |
| Normal-vs-N2 |
6.841200E-03 |
| N0-vs-N1 |
1.713020E-01 |
| N0-vs-N2 |
2.573800E-01 |
| N1-vs-N2 |
1.385810E-01 |
|
|
